Aptose Biosciences Inc (TSE:APS) (NASDAQ:APTO) is scheduled to be announcing its earnings results after the market closes on Tuesday, November 14th. Analysts expect the company to announce earnings of C($0.16) per share for the quarter.
Shares of Aptose Biosciences Inc (TSE:APS) opened at C$2.15 on Monday. Aptose Biosciences Inc has a 1-year low of C$1.05 and a 1-year high of C$2.38.
A number of brokerages recently weighed in on APS. HC Wainwright reissued a “buy” rating on shares of Aptose Biosciences in a research note on Thursday, September 7th. Roth Capital reissued a “buy” rating on shares of Aptose Biosciences in a research note on Monday, October 23rd.
COPYRIGHT VIOLATION NOTICE: “Aptose Biosciences Inc (APS) Set to Announce Quarterly Earnings on Tuesday” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://ledgergazette.com/2017/11/13/aptose-biosciences-inc-aps-set-to-announce-quarterly-earnings-on-tuesday.html.
Aptose Biosciences Company Profile
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Receive News & Ratings for Aptose Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.